Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Ingredient
3.2. Snippet by Dosage
3.3. Snippet by Application
3.4. Snippet by Age
3.5. Snippet by Distribution Channel
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing the Aging Population
4.1.1.2. Strategies Adopted by the Companies
4.1.2. Restraints
4.1.2.1. Competition from Alternate Food Sources
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Ingredient
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
7.1.2. Market Attractiveness Index, By Ingredient
7.2. Vitamins*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Botanicals
7.4. Minerals
7.5. Protein & Amino Acids
7.6. Omega Fatty Acids
7.7. Probiotics
7.8. Others
8. By Dosage
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
8.1.2. Market Attractiveness Index, By Dosage
8.2. Tablet*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Liquid
8.5. Powder
8.6. Others
9. Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Gastrointestinal Health*
9.2.1. Introduction
9.2.2. Market size and year-over-year growth analysis (%)
9.2.3. Gut Microbiota/Microbiome Balance
9.2.4. Digestion
9.2.5. Constipation
9.2.6. Bloating
9.2.7. Diarrhea
9.2.8. Leaky Gut
9.2.9. Inflammation
9.2.10. Gluten sensitivity
9.2.11. Abdominal Pain
9.2.12. GERD/Helicobacter pylori
9.2.13. Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
9.2.14. Gut Flora/Gut Microbiome Restoration
9.2.15. Others
9.3. Vaginal Health
9.4. Urinary Tract Health
9.4.1. Kidney Stones
9.4.2. UTIs
9.4.3. Others
9.5. Oral Health
9.6. Anti/Healthy Ageing
9.7. Allergies/Asthma
9.8. Bone & Joint Health
9.8.1. Osteoarthritis
9.8.2. Osteoporosis/Low Mineral Bone Density
9.8.3. Inflammation
9.9. Brain/Mental Health
9.9.1. Sleep
9.9.2. Cognition
9.9.3. Mood
9.9.4. Depression
9.9.5. Focus
9.10. Cardiovascular Health
9.11. Circulation
9.12. Energy/Fatigue Reduction
9.13. Metabolic Syndrome/Blood Glucose
9.14. Liver Health
9.15. Energy
9.16. Immunity/Respiratory Infections
9.17. Nutrient Absorption
9.18. Skin-Hair-Nails
9.18.1. Atopic Dermatitis & Eczema
9.18.2. Acne
9.18.3. Rosacea
9.18.4. Hair Growth/Hair Loss
9.18.5. Skin Microbiome
9.18.6. Others
9.19. Sports
9.20. Women’s Health
9.20.1. Fertility
9.20.2. Menopause
9.20.3. Pregnancy
9.20.4. Pcos
9.20.5. Vaginal Health & Health Vaginal Microbiome
9.20.6. Vaginal Infections (Bv/Vvc)
9.20.7. Pregnancy Outcomes
9.20.8. Others
9.21. Men’s Health & Men’s Fertility
9.22. Weight Management
9.23. Pediatric Health
9.23.1. Colic
9.23.2. Constipation
9.23.3. Regurgitation
9.23.4. Atopic Dermatitis
9.23.5. Others
9.24. Others
10. By Age
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
10.1.2. Market Attractiveness Index, By Age
10.2. Infant*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Children
10.4. Adults
10.5. Seniors
11. Distribution Channel
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.1.2. Market Attractiveness Index, By Distribution Channel
11.2. Supermarkets/Hypermarkets*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Pharmacies and Drug Stores
11.4. Convenience Stores
11.5. Online Retailers
11.6. Other Distribution Channels
12. Sustainability Analysis
12.1. Environmental Analysis
12.2. Economic Analysis
12.3. Governance Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. MEGA Lifesciences Public Company Limited*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Asian Phytoceuticals Public Company Limited
14.3. Khaolaor Laboratories Co., Ltd.
14.4. Giffarine Skyline Unity Co., Ltd.
14.5. BBGI Public Company Limited
14.6. Immortal Corporation Co., Ltd.
14.7. Inter Pharma Public Company Limited
14.8. Royce Lab International
14.9. Chame Corporation Public Company Limited
14.10. THAI HEALTH PRODUCT CO., LTD.
14.11. CEO Factory (Thailand) Co., Ltd. (LIST NOT EXHAUSTIVE)
15. Appendix
15.1. About Us and Services
15.2. Contact Us